Free Cash Flow for ResMed (RMD)
Free Cash Flow for ResMed (RMD): headline value $1.79B · YoY +29.2%. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
RMD
Currently viewingFree Cash FlowSwitch metric
Latest period
$1.79B
YoY change
+29.2%
5Y CAGR
+19.0%
Peak year (2025)
$1.66B
Latest annual
$1.66B
Free Cash Flow history chart for ResMed (RMD) from 1993 to 2025
Free Cash Flow history table for ResMed (RMD) from 1993 to 2025
| Fiscal year | Period ended | Reported | Free Cash Flow | YoY |
|---|---|---|---|---|
| 2025 | $1.66B | +29.2% | ||
| 2024 | $1.29B | +130.0% | ||
| 2023 | $559.30M | +186.7% | ||
| 2022 | $195.11M | -68.5% | ||
| 2021 | $619.89M | -11.0% | ||
| 2020 | $696.32M | +82.4% | ||
| 2019 | $381.71M | -12.0% | ||
| 2018 | $433.57M | +26.6% | ||
| 2017 | $342.58M | -28.6% | ||
| 2016 | $480.10M | +54.3% | ||
| 2015 | $311.24M | +0.4% | ||
| 2014 | $310.11M | -6.3% | ||
| 2013 | $331.04M | +2.8% | ||
| 2012 | $322.05M | +54.7% | ||
| 2011 | $208.19M | +64.5% | ||
| 2010 | $126.57M | +1.5% | ||
| 2009 | $124.66M | +100.9% | ||
| 2008 | $62.06M | +358.0% | ||
| 2007 | $13.55M | -464.1% | ||
| 2006 | -$3.72M | -111.9% | ||
| 2005 | $31.39M | +62.7% | ||
| 2004 | $19.30M | -42.7% | ||
| 2003 | $33.65M | +351.4% | ||
| 2002 | $7.46M | +261.7% | ||
| 2001 | $2.06M | -49.8% | ||
| 2000 | $4.11M | -195.5% | ||
| 1999 | -$4.30M | -14.0% | ||
| 1998 | -$5.00M | -190.9% | ||
| 1997 | $5.50M | +175.0% | ||
| 1996 | $2.00M | -281.8% | ||
| 1995 | -$1.10M | -184.6% | ||
| 1994 | $1.30M | +85.7% | ||
| 1993 | $700,000 | — |
Free Cash Flow values are taken from ResMed's reported cash flow statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
The 2025 reading of ResMed (RMD) free cash flow is $1.66B – grew 29.2% year-over-year.
Over 2020–2025 (5 years), ResMed free cash flow expanded at a +19.0% compound annual rate, sustaining 3 straight years of year-over-year growth.
The highest annual free cash flow of $1.66B was reported in 2025. The lowest in the available history was -$5.00M in 1998.
Within Healthcare, ResMed (RMD) ranks 9th among 8 peers we track. The peer median for free cash flow is $14.22B.
ResMed Free Cash Flow by Year
ResMed Free Cash Flow 2025: $1.66B
ResMed free cash flow in 2025 was $1.66B, grew 29.2% from 2024. This figure represents the highest annual value in the available history.
ResMed Free Cash Flow 2024: $1.29B
ResMed free cash flow in 2024 was $1.29B, surged 130.0% from 2023.
ResMed Free Cash Flow 2023: $559.30M
ResMed free cash flow in 2023 was $559.30M, surged 186.7% from 2022.
ResMed Free Cash Flow 2022: $195.11M
ResMed free cash flow in 2022 was $195.11M, plunged 68.5% below 2021.
ResMed Free Cash Flow 2021: $619.89M
ResMed free cash flow in 2021 was $619.89M.
See more financial history for ResMed (RMD).
Sector peers — Free Cash Flow
Companies in the same sector as ResMed, ranked by their latest free cash flow.
| Company | Free Cash Flow | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $28.99B | Healthcare |
| Johnson & Johnson (JNJ) | $19.70B | Healthcare |
| AbbVie Inc. (ABBV) | $17.82B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $16.07B | Healthcare |
| Merck & Co., Inc. (MRK) | $12.36B | Healthcare |
| AstraZeneca PLC (AZN) | $11.77B | Healthcare |
| Eli Lilly and Company (LLY) | $8.97B | Healthcare |
| Amgen Inc. (AMGN) | $8.10B | Healthcare |
Frequently asked questions
What is ResMed's free cash flow?
Latest reported free cash flow for ResMed (RMD) is $1.79B (period ending December 31, 2025).
How has ResMed free cash flow changed year-over-year?
ResMed (RMD) free cash flow changed +29.2% year-over-year on the latest annual filing.
What is the long-term growth rate of ResMed free cash flow?
ResMed (RMD) free cash flow compound annual growth rate is +19.0% over the most recent 5 years available.
When did ResMed free cash flow hit its highest annual value?
ResMed free cash flow reached its highest annual value of $1.66B in 2025.
What was ResMed free cash flow in 2024?
ResMed (RMD) free cash flow in 2024 was $1.29B.
What was ResMed free cash flow in 2025?
ResMed (RMD) free cash flow in 2025 was $1.66B.
Metrics overview
Pick a metric for charts, filings and peers — each row shows the latest TTM or most-recent-quarter value.
Explore more
RMD Overview
Company profile, financial tools, and key metrics
RMD Revenue Counter
Earns $171.17 every second. See per minute, hour, and day.
RMD Earnings Counter
Earns $47.12 per second net profit. See per minute, hour, and day.
RMD Economic Scale
Exceeds Eswatini's GDP. Compare with world economies.
RMD What If Invested
What if you had invested $1,000? See historical returns from any date.
RMD How It Makes Money
Discover visual breakdown of $5.40B in revenue — where it comes from and where it goes.
RMD Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
RMD Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
RMD Daily Price Character
Balanced · 50.4% historical win rate (green days). Streaks & record days.
RMD Buybacks
1.42% TTM buyback yield. Shareholder yield & SBC comparison.
RMD Stock Split History
4 splits on record. Dates, ratios, and cumulative multiple.
RMD Dividend Profile
Yield: 1.10%. Safety: 6/8. See full history.
RMD Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
RMD Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.